Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial

Meletios Α. Dimopoulos, Shaji Kumar, Vadim Doronin et al.|Blood Cancer Journal|2022

Cited by 21